Overview

Controlled Trial of Prenatal Vitamin D3 Supplementation to Prevent Vitamin D Deficiency in Mothers and Their Infants

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this research study is to compare the effects of higher dose vitamin D with commonly recommended dose in pregnant women to see which is better in achieving and/or maintaining sufficient vitamin D blood levels during pregnancy and in newborn infants as well as improving growth in the infant.
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborators:
Thrasher Research Fund
United Arab Emirates University
Treatments:
Cholecalciferol
Ergocalciferols
Vitamin D
Vitamins
Criteria
Inclusion Criteria:

- Women who are within the ages of 18-45 years

- In good general health

- 12 weeks pregnant (based on last menstrual period)

Exclusion Criteria:

- Mothers with preexisting type I or type II diabetes

- Mothers with preexisting hypertension

- Mothers with preexisting parathyroid disease or uncontrolled thyroid disease

- Mothers with multiple fetuses (e.g., twins, triplets, etc.)